Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta

American Journal of Pathology

Volumn 186, Issue 11, 2016, Pages 2970-2986

  Tabata, Takako ^a   Petitt, Matthew ^a   Fang Hoover, June ^a   Zydek, Martin ^a   Pereira, Lenore ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERLEUKIN 6; KI 67 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BCL XL; STAGE SPECIFIC EMBRYO ANTIGEN 4; STAT1 PROTEIN; STAT3 PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR SOX2; VIRAL PROTEIN;

AMNION; AMNION CELL; AMNION FLUID; AMNIOTIC EPITHELIAL CELL; ARTICLE; ASYMPTOMATIC DISEASE; CELL DIFFERENTIATION; CELL SURVIVAL; CLINICAL ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXPLANT; FETUS MEMBRANE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INNATE IMMUNITY; INTRAUTERINE GROWTH RETARDATION; MULTIVESICULAR BODY; PIGMENT CELL; PLACENTA DISORDER; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROGENY; RECURRENT DISEASE; SALIVA; UPREGULATION; VIRION; VIRUS INFECTION; VIRUS NEUTRALIZATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETUS; GESTATIONAL AGE; IMMUNOLOGY; METABOLISM; NEWBORN; PATHOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY COMPLICATION; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION;

AMNION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL GROWTH RETARDATION; FETUS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTERFERON-BETA; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84994829880     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.07.016     Document Type: Article

References (92)

1. 1 Pass, R.F., Stagno, S., Myers, G.J., Alford, C.A., Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 66 (1980), 758–762.
2. 2 Demmler, G.J., Congenital cytomegalovirus infection and disease. Adv Pediatr Infect Dis 11 (1996), 135–162.
3. 3 Cannon, M.J., Schmid, D.S., Hyde, T.B., Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20 (2010), 202–213.
4. 4 Colugnati, F.A., Staras, S.A., Dollard, S.C., Cannon, M.J., Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis, 7, 2007, 71.
5. 5 Maidji, E., Nigro, G., Tabata, T., McDonagh, S., Nozawa, N., Shiboski, S., Muci, S., Anceschi, M.M., Aziz, N., Adler, S.P., Pereira, L., Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 177 (2010), 1298–1310.
6. 6 Pereira, L., Petitt, M., Fong, A., Tsuge, M., Tabata, T., Fang-Hoover, J., Maidji, E., Zydek, M., Zhou, Y., Inoue, N., Loghavi, S., Pepkowitz, S., Kauvar, L.M., Ogunyemi, D., Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis 209 (2014), 1573–1584.
7. 7 Pereira, L., Maidji, E., McDonagh, S., Genbacev, O., Fisher, S., Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J Virol 77 (2003), 13301–13314.
8. 8 Pereira, L., Maidji, E., Cytomegalovirus infection in the human placenta: maternal immunity and developmentally regulated receptors on trophoblasts converge. Curr Top Microbiol Immunol 325 (2008), 383–395.
9. 9 Enders, G., Daiminger, A., Bader, U., Exler, S., Enders, M., Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52 (2011), 244–246.
10. 10 Stagno, S., Pass, R.F., Cloud, G., Britt, W.J., Henderson, R.E., Walton, P.D., Veren, D.A., Page, F., Alford, C.A., Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 256 (1986), 1904–1908.
11. 11 Rosenthal, L.S., Fowler, K.B., Boppana, S.B., Britt, W.J., Pass, R.F., Schmid, S.D., Stagno, S., Cannon, M.J., Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J 28 (2009), 515–520.
12. 12 Mussi-Pinhata, M.M., Yamamoto, A.Y., Moura Brito, R.M., de Lima Isaac, M., de Carvalho e Oliveira, P.F., Boppana, S., Britt, W.J., Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 49 (2009), 522–528.
13. 13 Revello, M.G., Gerna, G., Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol 29 (2004), 71–83.
14. 14 Revello, M.G., Zavattoni, M., Furione, M., Baldanti, F., Gerna, G., Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol 37 (1999), 3350–3352.
15. 15 Gouarin, S., Palmer, P., Cointe, D., Rogez, S., Vabret, A., Rozenberg, F., Denis, F., Freymuth, F., Lebon, P., Grangeot-Keros, L., Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR. J Clin Virol 21 (2001), 47–55.
16. 16 Liesnard, C., Donner, C., Brancart, F., Gosselin, F., Delforge, M.L., Rodesch, F., Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 95 (2000), 881–888.
17. 17 Antsaklis, A.J., Daskalakis, G.J., Mesogitis, S.A., Koutra, P.T., Michalas, S.S., Prenatal diagnosis of fetal primary cytomegalovirus infection. BJOG 107 (2000), 84–88.
18. 18 Benirschke, K., Kaufmann, P., Pathology of the Human Placenta. 2000, Springer, New York, 616–636.
19. 19 Underwood, M.A., Gilbert, W.M., Sherman, M.P., Amniotic fluid: not just fetal urine anymore. J Perinatol 25 (2005), 341–348.
20. 20 Buhimschi, C.S., Bhandari, V., Hamar, B.D., Bahtiyar, M.O., Zhao, G., Sfakianaki, A.K., Pettker, C.M., Magloire, L., Funai, E., Norwitz, E.R., Paidas, M., Copel, J.A., Weiner, C.P., Lockwood, C.J., Buhimschi, I.A., Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med, 4, 2007, e18.
21. 21 Buhimschi, C.S., Dulay, A.T., Abdel-Razeq, S., Zhao, G., Lee, S., Hodgson, E.J., Bhandari, V., Buhimschi, I.A., Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG 116 (2009), 257–267.
22. 22 Miki, T., Lehmann, T., Cai, H., Stolz, D.B., Strom, S.C., Stem cell characteristics of amniotic epithelial cells. Stem Cells 23 (2005), 1549–1559.
23. 23 Li, H., Niederkorn, J.Y., Neelam, S., Mayhew, E., Word, R.A., McCulley, J.P., Alizadeh, H., Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 46 (2005), 900–907.
24. 24 Hao, Y., Ma, D.H., Hwang, D.G., Kim, W.S., Zhang, F., Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 19 (2000), 348–352.
25. 25 Keelan, J.A., Sato, T., Mitchell, M.D., Interleukin (IL)-6 and IL-8 production by human amnion: regulation by cytokines, growth factors, glucocorticoids, phorbol esters, and bacterial lipopolysaccharide. Biol Reprod 57 (1997), 1438–1444.
26. 26 Gervasi, M.T., Romero, R., Bracalente, G., Erez, O., Dong, Z., Hassan, S.S., Yeo, L., Yoon, B.H., Chaiworapongsa, T., Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 40 (2012), 329–343.
27. 27 Scott, G.M., Chow, S.S., Craig, M.E., Pang, C.N., Hall, B., Wilkins, M.R., Jones, C.A., Lloyd, A.R., Rawlinson, W.D., Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205 (2012), 1305–1310.
28. 28 Tabata, T., Petitt, M., Puerta-Guardo, H., Michlmayr, D., Wang, C., Fang-Hoover, J., Harris, E., Pereira, L., Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe 20 (2016), 1–12.
29. 29 Miki, T., Mitamura, K., Ross, M.A., Stolz, D.B., Strom, S.C., Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J Reprod Immunol 75 (2007), 91–96.
30. 30 Revello, M.G., Baldanti, F., Percivalle, E., Sarasini, A., De-Giuli, L., Genini, E., Lilleri, D., Labo, N., Gerna, G., In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol 82 (2001), 1429–1438.
31. 31 Scrivano, L., Sinzger, C., Nitschko, H., Koszinowski, U.H., Adler, B., HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog, 7, 2011, e1001256.
32. 32 Pereira, L., Hoffman, M., Tatsuno, M., Dondero, D., Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139 (1984), 73–86.
33. 33 Dondero, D.V., Pereira, L., Monoclonal Antibody Production. 1990, American Public Health Association, Washington, DC, 101–124.
34. 34 Lilley, B.N., Ploegh, H.L., Tirabassi, R.S., Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 75 (2001), 11218–11221.
35. 35 Navarro, D., Paz, P., Tugizov, S., Topp, K., La Vail, J., Pereira, L., Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197 (1993), 143–158.
36. 36 Nozawa, N., Fang-Hoover, J., Tabata, T., Maidji, E., Pereira, L., Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J Clin Virol 46 Suppl 4 (2009), S58–S63.
37. 37 Zydek, M., Petitt, M., Fang-Hoover, J., Adler, B., Kauvar, L.M., Pereira, L., Tabata, T., HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex. Viruses 6 (2014), 1346–1364.
38. 38 Enders, G., Bader, U., Lindemann, L., Schalasta, G., Daiminger, A., Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 21 (2001), 362–377.
39. 39 Daiminger, A., Bader, U., Enders, G., Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG 112 (2005), 166–172.
40. 40 Gerna, G., Sarasini, A., Patrone, M., Percivalle, E., Fiorina, L., Campanini, G., Gallina, A., Baldanti, F., Revello, M.G., Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 89 (2008), 853–865.
41. 41 Ross, S.A., Ahmed, A., Palmer, A.L., Michaels, M.G., Sanchez, P.J., Bernstein, D.I., Tolan, R.W. Jr., Novak, Z., Chowdhury, N., Fowler, K.B., Boppana, S.B., Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis 210 (2014), 1415–1418.
42. 42 Boppana, S.B., Ross, S.A., Shimamura, M., Palmer, A.L., Ahmed, A., Michaels, M.G., Sanchez, P.J., Bernstein, D.I., Tolan, R.W. Jr., Novak, Z., Chowdhury, N., Britt, W.J., Fowler, K.B., Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 364 (2011), 2111–2118.
43. 43 Boppana, S.B., Ross, S.A., Novak, Z., Shimamura, M., Tolan, R.W. Jr., Palmer, A.L., Ahmed, A., Michaels, M.G., Sanchez, P.J., Bernstein, D.I., Britt, W.J., Fowler, K.B., Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 303 (2010), 1375–1382.
44. 44 Izumi, M., Pazin, B.J., Minervini, C.F., Gerlach, J., Ross, M.A., Stolz, D.B., Turner, M.E., Thompson, R.L., Miki, T., Quantitative comparison of stem cell marker-positive cells in fetal and term human amnion. J Reprod Immunol 81 (2009), 39–43.
45. 45 Evron, A., Goldman, S., Shalev, E., Human amniotic epithelial cells cultured in substitute serum medium maintain their stem cell characteristics for up to four passages. Int J Stem Cells 4 (2011), 123–132.
46. 46 Lilleri, D., Kabanova, A., Revello, M.G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D., Gerna, G., Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. PLoS One, 8, 2013, e59863.
47. 47 Cui, X., Lee, R., Adler, S.P., McVoy, M.A., Antibody inhibition of human cytomegalovirus spread in epithelial cell cultures. J Virol Methods 192 (2013), 44–50.
48. 48 Wang, D., Li, F., Freed, D.C., Finnefrock, A.C., Tang, A., Grimes, S.N., Casimiro, D.R., Fu, T.M., Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection. Vaccine 29 (2011), 9075–9080.
49. 49 Vanarsdall, A.L., Chase, M.C., Johnson, D.C., Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J Virol 85 (2011), 11638–11645.
50. 50 Genini, E., Percivalle, E., Sarasini, A., Revello, M.G., Baldanti, F., Gerna, G., Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections. J Clin Virol 52 (2011), 113–118.
51. 51 Vanarsdall, A.L., Ryckman, B.J., Chase, M.C., Johnson, D.C., Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J Virol 82 (2008), 11837–11850.
52. 52 Cui, X., Meza, B.P., Adler, S.P., McVoy, M.A., Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine 26 (2008), 5760–5766.
53. 53 Das, S., Pellett, P.E., Spatial relationships between markers for secretory and endosomal machinery in human cytomegalovirus-infected cells versus those in uninfected cells. J Virol 85 (2011), 5864–5879.
54. 54 Das, S., Vasanji, A., Pellett, P.E., Three-dimensional structure of the human cytomegalovirus cytoplasmic virion assembly complex includes a reoriented secretory apparatus. J Virol 81 (2007), 11861–11869.
55. 55 Sanchez, V., Greis, K.D., Sztul, E., Britt, W.J., Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J Virol 74 (2000), 975–986.
56. 56 Tandon, R., AuCoin, D.P., Mocarski, E.S., Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol 83 (2009), 10797–10807.
57. 57 Baldanti, F., Paolucci, S., Campanini, G., Sarasini, A., Percivalle, E., Revello, M.G., Gerna, G., Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates. Arch Virol 151 (2006), 1225–1233.
58. 58 Hahn, G., Revello, M.G., Patrone, M., Percivalle, E., Campanini, G., Sarasini, A., Wagner, M., Gallina, A., Milanesi, G., Koszinowski, U., Baldanti, F., Gerna, G., Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78 (2004), 10023–10033.
59. 59 Macagno, A., Bernasconi, N.L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M.G., Gerna, G., Sallusto, F., Lanzavecchia, A., Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 84 (2010), 1005–1013.
60. 60 Zhang, L., Pagano, J.S., Structure and function of IRF-7. J Interferon Cytokine Res 22 (2002), 95–101.
61. 61 Lin, R., Heylbroeck, C., Pitha, P.M., Hiscott, J., Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18 (1998), 2986–2996.
62. 62 Sato, M., Hata, N., Asagiri, M., Nakaya, T., Taniguchi, T., Tanaka, N., Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441 (1998), 106–110.
63. 63 DeFilippis, V.R., Robinson, B., Keck, T.M., Hansen, S.G., Nelson, J.A., Fruh, K.J., Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection. J Virol 80 (2006), 1032–1037.
64. 64 Taylor, R.T., Bresnahan, W.A., Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. J Virol 79 (2005), 3873–3877.
65. 65 Adler, B., Scrivano, L., Ruzcics, Z., Rupp, B., Sinzger, C., Koszinowski, U., Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J Gen Virol 87 (2006), 2451–2460.
66. 66 Siddiquee, K., Zhang, S., Guida, W.C., Blaskovich, M.A., Greedy, B., Lawrence, H.R., Yip, M.L., Jove, R., McLaughlin, M.M., Lawrence, N.J., Sebti, S.M., Turkson, J., Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci U S A 104 (2007), 7391–7396.
67. 67 Ferrajoli, A., Faderl, S., Van, Q., Koch, P., Harris, D., Liu, Z., Hazan-Halevy, I., Wang, Y., Kantarjian, H.M., Priebe, W., Estrov, Z., WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res 67 (2007), 11291–11299.
68. 68 Kumar, A., Bora, U., Molecular docking studies on inhibition of Stat3 dimerization by curcumin natural derivatives and its conjugates with amino acids. Bioinformation 8 (2012), 988–993.
69. 69 Fish, K.N., Soderberg-Naucler, C., Mills, L.K., Stenglein, S., Nelson, J.A., Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72 (1998), 5661–5668.
70. 70 Dunn, K.C., Aotaki, K.A., Putkey, F.R., Hjelmeland, L.M., ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62 (1996), 155–169.
71. 71 Tugizov, S., Maidji, E., Pereira, L., Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells. J Gen Virol 77 (1996), 61–74.
72. 72 Browne, E.P., Shenk, T., Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A 100 (2003), 11439–11444.
73. 73 Wendlandt, E.B., Graff, J.W., Gioannini, T.L., McCaffrey, A.P., Wilson, M.E., The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-kappaB activation. Innate Immun 18 (2012), 846–855.
74. 74 Wang, F.Z., Weber, F., Croce, C., Liu, C.G., Liao, X., Pellett, P.E., Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol 82 (2008), 9065–9074.
75. 75 O'Connor, C.M., Vanicek, J., Murphy, E.A., Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency. J Virol 88 (2014), 5524–5532.
76. 76 Korpal, M., Ell, B.J., Buffa, F.M., Ibrahim, T., Blanco, M.A., Celia-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., Wei, Y., Hu, G., Garcia, B.A., Ragoussis, J., Amadori, D., Harris, A.L., Kang, Y., Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17 (2011), 1101–1108.
77. 77 Sen, N., Che, X., Rajamani, J., Zerboni, L., Sung, P., Ptacek, J., Arvin, A.M., Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proc Natl Acad Sci U S A 109 (2012), 600–605.
78. 78 Faqing, T., Zhi, H., Liqun, Y., Min, T., Huanhua, G., Xiyun, D., Ya, C., Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. Exp Oncol 27 (2005), 96–101.
79. 79 Wang, Z., Luo, F., Li, L., Yang, L., Hu, D., Ma, X., Lu, Z., Sun, L., Cao, Y., STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 and ERK signaling. Eur J Cancer 46 (2010), 2996–3006.
80. 80 Gires, O., Kohlhuber, F., Kilger, E., Baumann, M., Kieser, A., Kaiser, C., Zeidler, R., Scheffer, B., Ueffing, M., Hammerschmidt, W., Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 18 (1999), 3064–3073.
81. 81 Lu, J., Verma, S.C., Murakami, M., Cai, Q., Kumar, P., Xiao, B., Robertson, E.S., Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-associated B-lymphoma cells and contributes to their proliferation. J Virol 83 (2009), 7129–7141.
82. 82 Botto, S., Streblow, D.N., DeFilippis, V., White, L., Kreklywich, C.N., Smith, P.P., Caposio, P., IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin. Blood 117 (2011), 352–361.
83. 83 Lepiller, Q., Abbas, W., Kumar, A., Tripathy, M.K., Herbein, G., HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes. PLoS One, 8, 2013, e59591.
84. 84 Smith, G.B., Mocarski, E.S., Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol 79 (2005), 14923–14932.
85. 85 Yurochko, A.D., Mayo, M.W., Poma, E.E., Baldwin, A.S. Jr., Huang, E.S., Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J Virol 71 (1997), 4638–4648.
86. 86 Juckem, L.K., Boehme, K.W., Feire, A.L., Compton, T., Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J Immunol 180 (2008), 4965–4977.
87. 87 Yurochko, A.D., Kowalik, T.F., Huong, S.M., Huang, E.S., Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 69 (1995), 5391–5400.
88. 88 Collins-McMillen, D., Kim, J.H., Nogalski, M.T., Stevenson, E.V., Chan, G.C., Caskey, J.R., Cieply, S.J., Yurochko, A.D., Human cytomegalovirus promotes survival of infected monocytes via a distinct temporal regulation of cellular Bcl-2 family proteins. J Virol 90 (2015), 2356–2371.
89. 89 Carlquist, J.F., Edelman, L., Bennion, D.W., Anderson, J.L., Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-kappaB. J Infect Dis 179 (1999), 1094–1100.
90. 90 Iwamoto, G.K., Konicek, S.A., Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression. J Investig Med 45 (1997), 175–182.
91. 91 Terasaka, Y., Miyazaki, D., Yakura, K., Haruki, T., Inoue, Y., Induction of IL-6 in transcriptional networks in corneal epithelial cells after herpes simplex virus type 1 infection. Invest Ophthalmol Vis Sci 51 (2010), 2441–2449.
92. 92 Reitsma, J.M., Sato, H., Nevels, M., Terhune, S.S., Paulus, C., Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus. J Virol 87 (2013), 10763–10776.